Investor Information
Stock information
| Shareholder structure | |
|---|---|
Based on the declarations required by law and by the by-laws received by the Company, its shareholding structure is: | |
| Public | 93,97% |
| Main shareholders | Bpifrance Participations SA (ex FSI) – 3,46% New Enterprise Associates – 1,24% |
| Founding managers | 1,11% |
| Share capital | €25 004 543 |
| Number of outstanding shares | 24 963 009 |
| Number of voting rights as of August 31, 2016 | |
| Total number of voting rights calculated on the basis of all the shares to which voting rights are attached even if exercise thereof is suspended | 24 963 009 |
| Reverse stock split | |
| Liquidity contract with Gilbert Dupont | |
| Eligibility PEA-PME 2016-2017 (document in French) |  |
| Share price | Euronext |
| Analyst coverage | |
| Euroclear France code | 7413 |
| Reuters code | NCOX.PA |
| Bloomberg code | COX.FP |
| NYSE Euronext | CAC Mids & Smalls |
| FTSE Classification | Economical group: non cyclical consumer goods (40) Industrial sector: pharmaceuticals (48) Industry sub-sector: pharmaceuticals (480) |
| Listing Segment | Euronext Paris: Eurolist Next Economy |